260 related articles for article (PubMed ID: 29367740)
1. Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials.
Korbee CJ; Heemskerk MT; Kocev D; van Strijen E; Rabiee O; Franken KLMC; Wilson L; Savage NDL; Džeroski S; Haks MC; Ottenhoff THM
Nat Commun; 2018 Jan; 9(1):358. PubMed ID: 29367740
[TBL] [Abstract][Full Text] [Related]
2. Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections.
Heemskerk MT; Korbee CJ; Esselink JJ; Dos Santos CC; van Veen S; Gordijn IF; Vrieling F; Walburg KV; Engele CG; Dijkman K; Wilson L; Verreck FAW; Ottenhoff THM; Haks MC
Sci Rep; 2021 Oct; 11(1):19634. PubMed ID: 34608194
[TBL] [Abstract][Full Text] [Related]
3. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
Front Immunol; 2020; 11():36. PubMed ID: 32117228
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Integrating chemical and genetic silencing strategies to identify host kinase-phosphatase inhibitor networks that control bacterial infection.
Albers HM; Kuijl C; Bakker J; Hendrickx L; Wekker S; Farhou N; Liu N; Blasco-Moreno B; Scanu T; den Hertog J; Celie P; Ovaa H; Neefjes J
ACS Chem Biol; 2014 Feb; 9(2):414-22. PubMed ID: 24274083
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of
van Doorn CLR; Schouten GK; van Veen S; Walburg KV; Esselink JJ; Heemskerk MT; Vrieling F; Ottenhoff THM
Front Immunol; 2021; 12():739938. PubMed ID: 34552598
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
[TBL] [Abstract][Full Text] [Related]
8. Targeting of host cell receptor tyrosine kinases by intracellular pathogens.
Haqshenas G; Doerig C
Sci Signal; 2019 Sep; 12(599):. PubMed ID: 31530732
[TBL] [Abstract][Full Text] [Related]
9. Acetate Kinase (AcK) is Essential for Microbial Growth and Betel-derived Compounds Potentially Target AcK, PhoP and MDR Proteins in M. tuberculosis, V. cholerae and Pathogenic E. coli: An in silico and in vitro Study.
Tiwari S; Barh D; Imchen M; Rao E; Kumavath RK; Seenivasan SP; Jaiswal AK; Jamal SB; Kumar V; Ghosh P; Azevedo V
Curr Top Med Chem; 2018; 18(31):2731-2740. PubMed ID: 30663567
[TBL] [Abstract][Full Text] [Related]
10. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1.
Kuijl C; Savage ND; Marsman M; Tuin AW; Janssen L; Egan DA; Ketema M; van den Nieuwendijk R; van den Eeden SJ; Geluk A; Poot A; van der Marel G; Beijersbergen RL; Overkleeft H; Ottenhoff TH; Neefjes J
Nature; 2007 Nov; 450(7170):725-30. PubMed ID: 18046412
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.
Brandis G; Pietsch F; Alemayehu R; Hughes D
J Antimicrob Chemother; 2015 Mar; 70(3):680-5. PubMed ID: 25362573
[TBL] [Abstract][Full Text] [Related]
12. Autophagy: A new strategy for host-directed therapy of tuberculosis.
Paik S; Kim JK; Chung C; Jo EK
Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337
[TBL] [Abstract][Full Text] [Related]
13. Transferring knowledge of bacterial protein interaction networks to predict pathogen targeted human genes and immune signaling pathways: a case study on M. tuberculosis.
Mei S; Flemington EK; Zhang K
BMC Genomics; 2018 Jun; 19(1):505. PubMed ID: 29954330
[TBL] [Abstract][Full Text] [Related]
14. Host-directed Therapy: A New Arsenal to Come.
Mohan M; Bhattacharya D
Comb Chem High Throughput Screen; 2021; 24(1):59-70. PubMed ID: 32723230
[TBL] [Abstract][Full Text] [Related]
15. High-throughput screening of a collection of known pharmacologically active small compounds for inhibitors of Salmonella invasion and intracellular replication.
Ridge Y; Landini P; Thompson A
J Appl Microbiol; 2018 Sep; 125(3):724-730. PubMed ID: 29693760
[TBL] [Abstract][Full Text] [Related]
16. Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis.
Li Q; Karim AF; Ding X; Das B; Dobrowolski C; Gibson RM; Quiñones-Mateu ME; Karn J; Rojas RE
Sci Rep; 2016 Jun; 6():27566. PubMed ID: 27297123
[TBL] [Abstract][Full Text] [Related]
17. Host-directed therapies for tuberculosis: quantitative systems pharmacology approaches.
Mehta K; Spaink HP; Ottenhoff THM; van der Graaf PH; van Hasselt JGC
Trends Pharmacol Sci; 2022 Apr; 43(4):293-304. PubMed ID: 34916092
[TBL] [Abstract][Full Text] [Related]
18. Modulating Iron for Metabolic Support of TB Host Defense.
Phelan JJ; Basdeo SA; Tazoll SC; McGivern S; Saborido JR; Keane J
Front Immunol; 2018; 9():2296. PubMed ID: 30374347
[TBL] [Abstract][Full Text] [Related]
19. Signalling inhibitors against Mycobacterium tuberculosis--early days of a new therapeutic concept in tuberculosis.
Hegymegi-Barakonyi B; Székely R; Varga Z; Kiss R; Borbély G; Németh G; Bánhegyi P; Pató J; Greff Z; Horváth Z; Mészáros G; Marosfalvi J; Erōs D; Szántai-Kis C; Breza N; Garavaglia S; Perozzi S; Rizzi M; Hafenbradl D; Ko M; Av-Gay Y; Klebl BM; Orfi L; Kéri G
Curr Med Chem; 2008; 15(26):2760-70. PubMed ID: 18991635
[TBL] [Abstract][Full Text] [Related]
20. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
